609.70 -10.95 (-1.76%)

Near 52W Low

538.0K NSE+BSE Volume

NSE Jun 30, 2022 11:59 AM



Lupin Ltd.    
28 Jun 2022, 05:54PM
609.70
-1.76%
default
Lupin Ltd.    
27 Jun 2022
609.70
-1.76%
Lupin Ltd.    
17 Jun 2022
609.70
-1.76%
Lupin Ltd.    
15 Jun 2022
609.70
-1.76%
Lupin Ltd.    
10 Jun 2022
609.70
-1.76%
Lupin Ltd.    
09 Jun 2022
609.70
-1.76%
Lupin receives tentative approval from USFDA to market Ivacaftor tablets
Lupin receives tentative approval from USFDA to market Ivacaftor tablets
Business Standard
The product is the generic equivalent of Vertex Pharmaceuticals' Kalydeco tablets, Lupin said in a statement
default
Lupin Ltd.    
08 Jun 2022
609.70
-1.76%
Lupin Ltd.    
03 Jun 2022
609.70
-1.76%
Indian pharma firms hiring former USFDA officers to tide over compliance issues
Indian pharma firms hiring former USFDA officers to tide over compliance issues
Moneycontrol
Lupin has hired a former USFDA officer to tide over compliance issues and it is not the only company to do so. The street believes this will help the company but past such hirings have not always been successful.
Lupin Ltd. has lost -47.49% in the last 1 Year
Lupin Ltd.    
02 Jun 2022
609.70
-1.76%
Lupin Ltd.    
31 May 2022
609.70
-1.76%
796 Votes:
Buy 72.36%
Sell 17.84%
Hold 9.8%
BUY
SELL
HOLD
All reports of LUPIN